中国糖尿病杂志
中國糖尿病雜誌
중국당뇨병잡지
CHINESE JOURNAL OF DIABETES
2000年
4期
219-223
,共5页
马学毅%潘国敏%陈戴蕤%贝建中%王身国
馬學毅%潘國敏%陳戴蕤%貝建中%王身國
마학의%반국민%진대유%패건중%왕신국
糖尿病%口服胰岛素%微囊
糖尿病%口服胰島素%微囊
당뇨병%구복이도소%미낭
Diabetes Oral insulin Microcapsule
目的观察改变了材料分子量、微囊粒径后的聚丙交酯胰岛素微囊(PLA-MCI)体外释药及大鼠口服后血糖的变化.方法体外释药在磷酸盐缓冲液(PBS)中进行,胰岛素测定用福林-酚法.体内实验由糖尿病大鼠口服PLA-MCI后每小时血糖测定反映,并与口服纯胰岛素的二组对照及同期饥饿对照组血糖进行比较.结果 PLA-MCI在PBS中3~7小时内释放了51.0%~73 .4% 的胰岛素,11小时后释放达稳态.口服PLA-MCI后大鼠血糖下降达80.9±10.8%(n=10 ),显著高于口服等量纯胰岛素的正常大鼠(31.0±15.1%,n=6)和糖尿病大鼠(47.0±2 7.9%,n=5)以及未服药同期饥饿对照糖尿病大鼠(40.0±16.7%,n=7)(P均< 0.001).PLA-MCI与水预混1小时后口服,体内降血糖峰时为1~3小时,持续作用10~12小时.PLA-MCI在PBS液中温育3周,电镜下仍见基本完整形态.结论减少PLA分子量,增加微球粒径加快了胰岛素从PLA-MCI中的释放,提高了其口服后降血糖效应,并保持其缓慢降解特性,具有良好的安全性.
目的觀察改變瞭材料分子量、微囊粒徑後的聚丙交酯胰島素微囊(PLA-MCI)體外釋藥及大鼠口服後血糖的變化.方法體外釋藥在燐痠鹽緩遲液(PBS)中進行,胰島素測定用福林-酚法.體內實驗由糖尿病大鼠口服PLA-MCI後每小時血糖測定反映,併與口服純胰島素的二組對照及同期饑餓對照組血糖進行比較.結果 PLA-MCI在PBS中3~7小時內釋放瞭51.0%~73 .4% 的胰島素,11小時後釋放達穩態.口服PLA-MCI後大鼠血糖下降達80.9±10.8%(n=10 ),顯著高于口服等量純胰島素的正常大鼠(31.0±15.1%,n=6)和糖尿病大鼠(47.0±2 7.9%,n=5)以及未服藥同期饑餓對照糖尿病大鼠(40.0±16.7%,n=7)(P均< 0.001).PLA-MCI與水預混1小時後口服,體內降血糖峰時為1~3小時,持續作用10~12小時.PLA-MCI在PBS液中溫育3週,電鏡下仍見基本完整形態.結論減少PLA分子量,增加微毬粒徑加快瞭胰島素從PLA-MCI中的釋放,提高瞭其口服後降血糖效應,併保持其緩慢降解特性,具有良好的安全性.
목적관찰개변료재료분자량、미낭립경후적취병교지이도소미낭(PLA-MCI)체외석약급대서구복후혈당적변화.방법체외석약재린산염완충액(PBS)중진행,이도소측정용복림-분법.체내실험유당뇨병대서구복PLA-MCI후매소시혈당측정반영,병여구복순이도소적이조대조급동기기아대조조혈당진행비교.결과 PLA-MCI재PBS중3~7소시내석방료51.0%~73 .4% 적이도소,11소시후석방체은태.구복PLA-MCI후대서혈당하강체80.9±10.8%(n=10 ),현저고우구복등량순이도소적정상대서(31.0±15.1%,n=6)화당뇨병대서(47.0±2 7.9%,n=5)이급미복약동기기아대조당뇨병대서(40.0±16.7%,n=7)(P균< 0.001).PLA-MCI여수예혼1소시후구복,체내강혈당봉시위1~3소시,지속작용10~12소시.PLA-MCI재PBS액중온육3주,전경하잉견기본완정형태.결론감소PLA분자량,증가미구립경가쾌료이도소종PLA-MCI중적석방,제고료기구복후강혈당효응,병보지기완만강해특성,구유량호적안전성.
Objective In order to improve the blood glucose(BG) lowing effect of polylactide acid microcapsulated insulin (PLA MCI),we changed the molecular weight of PLA,diameter of microsphere and observed the release profile of this new PLA MCI in PBS buffer,as well as the changes of peripheral BG in diabetic rats after feeding.Methods Release profile in vitro was made in PBS buffer,the insulin was measured by follin phenol method.In vivo the BG lowing effect of PLA MCI was studied in 4 groups of rats.Group 1 was normal rats ( n =6), group 2 was diabetic rats ( n =5),all these rats in both groups were fed by 2.4mg of pure insulin.Group 3 was diabetic rats ( n =10) fed by PLA MCI contained 2.4 mg of insulin.Group 4 was starve DM rats control group without any oral drug ( n =7).In the rats of 4 groups BG were measured every hour until BG returned to control level.The BG changes were compared among 4 groups.Results In vitro during 3~7h about 51.0%~73.4% of insulin had been released from PLA MCI.In vivo the maximum BG decreases were 31.0±15.1% in group 1,47.0±27.9% in group 2,40.0±16.7% in group 4 and 80.9±10.8% in group 3 during 13 hours.The BG lowing effect of PLA MCI began at 30 minutes,the peak times were in 1 to 3 hours after ingestion,the effect persisted for 10~12 hours.Under the scanning electron microscope the PLA MCI showed a intact shape but with many small hole surface after incubation in PBS and 1% lipase for 3 weeks.Conclusion By decrease of the molecular weight of PLA,and thinning wall of microsphere as well as increase of the diameter of microsphere,the insulin release rate was increased from PLA MCI, which also improved BG lowing effect in vivo after ingestion.Since PLA MCI still kept its slow degradation after 3 weeks,it may be in a good safety after ingestion.